Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/12687
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKaukonen, Kirsi-Maijaen
dc.contributor.authorBailey, Michael Jen
dc.contributor.authorPilcher, David Ven
dc.contributor.authorCooper, David Jamesen
dc.contributor.authorBellomo, Rinaldoen
dc.date.accessioned2015-05-16T02:24:56Z-
dc.date.available2015-05-16T02:24:56Z-
dc.date.issued2015-03-17en
dc.identifier.citationThe New England Journal of Medicine 2015; 372(17): 1629-38en
dc.identifier.govdoc25776936en
dc.identifier.otherPUBMEDen
dc.identifier.urihttp://ahro.austin.org.au/austinjspui/handle/1/12687en
dc.description.abstractThe consensus definition of severe sepsis requires suspected or proven infection, organ failure, and signs that meet two or more criteria for the systemic inflammatory response syndrome (SIRS). We aimed to test the sensitivity, face validity, and construct validity of this approach.We studied data from patients from 172 intensive care units in Australia and New Zealand from 2000 through 2013. We identified patients with infection and organ failure and categorized them according to whether they had signs meeting two or more SIRS criteria (SIRS-positive severe sepsis) or less than two SIRS criteria (SIRS-negative severe sepsis). We compared their characteristics and outcomes and assessed them for the presence of a step increase in the risk of death at a threshold of two SIRS criteria.Of 1,171,797 patients, a total of 109,663 had infection and organ failure. Among these, 96,385 patients (87.9%) had SIRS-positive severe sepsis and 13,278 (12.1%) had SIRS-negative severe sepsis. Over a period of 14 years, these groups had similar characteristics and changes in mortality (SIRS-positive group: from 36.1% [829 of 2296 patients] to 18.3% [2037 of 11,119], P<0.001; SIRS-negative group: from 27.7% [100 of 361] to 9.3% [122 of 1315], P<0.001). Moreover, this pattern remained similar after adjustment for baseline characteristics (odds ratio in the SIRS-positive group, 0.96; 95% confidence interval [CI], 0.96 to 0.97; odds ratio in the SIRS-negative group, 0.96; 95% CI, 0.94 to 0.98; P=0.12 for between-group difference). In the adjusted analysis, mortality increased linearly with each additional SIRS criterion (odds ratio for each additional criterion, 1.13; 95% CI, 1.11 to 1.15; P<0.001) without any transitional increase in risk at a threshold of two SIRS criteria.The need for two or more SIRS criteria to define severe sepsis excluded one in eight otherwise similar patients with infection, organ failure, and substantial mortality and failed to define a transition point in the risk of death. (Funded by the Australian and New Zealand Intensive Care Research Centre.).en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAustraliaen
dc.subject.otherDatabases, Factualen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherIntensive Care Unitsen
dc.subject.otherMaleen
dc.subject.otherMiddle Ageden
dc.subject.otherMultiple Organ Failureen
dc.subject.otherNew Zealanden
dc.subject.otherOdds Ratioen
dc.subject.otherOrgan Dysfunction Scoresen
dc.subject.otherRetrospective Studiesen
dc.subject.otherSensitivity and Specificityen
dc.subject.otherSepsis.classification.diagnosis.mortalityen
dc.subject.otherSeverity of Illness Indexen
dc.subject.otherSystemic Inflammatory Response Syndrome.classification.diagnosis.mortalityen
dc.titleSystemic inflammatory response syndrome criteria in defining severe sepsis.en
dc.typeJournal Articleen
dc.identifier.journaltitleThe New England Journal of Medicineen
dc.identifier.affiliationFrom the Australian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University (K.-M.K., M.B., D.P., D.J.C., R.B.), the Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (D.P.), and the Department of Intensive Care, Alfred Hospital (D.P.), Melbourne, VIC, and the Intensive Care Unit, Austin Health, Heidelberg, VIC (R.B.) - all in Australiaen
dc.identifier.affiliationand the Neurosurgical Unit, Department of Anesthesiology, Intensive Care and Pain Medicine, Helsinki University Central Hospital, Helsinki (K.-M.K.).en
dc.identifier.doi10.1056/NEJMoa1415236en
dc.description.pages1629-38en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/25776936en
dc.type.austinJournal Articleen
item.grantfulltextnone-
item.languageiso639-1en-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

8
checked on Feb 6, 2023

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.